Krabbe Disease Clinical Trial
Official title:
Lysosomal Storage Disease: Health, Development, and Functional Outcome Surveillance in Preschool Children
Hypothesis: Children diagnosed with a lysosomal disease will exhibit developmental, adaptive, and behavioral strengths and difficulties depending upon 1) biomedical risk factors (i.e. the specific genetic disorder responsible for the illness); 2) available modifying interventions, whether medical or behavioral; and 3) social risks in the children's families, neighborhoods and communities. A valid and reliable telephone-based surveillance system can successfully collect the data required to elucidate these developmental, adaptive and behavioral strengths and difficulties.
Children who have lysosomal disease experience declines in health status and central nervous
system integrity which result in motor, communication, self-care, learning and behavioral
challenges. Medical interventions such as enzyme replacement therapy (ERT) and hematopoietic
stem cell transplantation can improve the health and functioning of children with lysosomal
disease. To date, however, there is no established system for evaluating the health status,
developmental status, behavioral outcomes or functional outcomes of these preschool-aged
children across time and differing settings. The primary objective of this study is to
develop a valid and reliable telephone-based data-gathering system for obtaining health
status data, developmental status data, behavioral outcomes data, and functional outcomes
data which reflect skills of daily living including feeding, moving, communicating and
responding to others.
The secondary objective of this study is to assess the validity of several early-childhood
standardized assessment tools as compared to the standard neuropsychological assessment
battery specified by the Lysosomal Disease Network's 'Neurobehavioral Core.'
The third objective of this study is to describe the impact of lysosomal disease upon the
families of lysosomal disease-affected children.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02993796 -
Krabbe Disease Global Patient Registry
|
||
Enrolling by invitation |
NCT03655223 -
Early Check: Expanded Screening in Newborns
|
||
Active, not recruiting |
NCT04693598 -
Gene Transfer Clinical Trial for Krabbe Disease
|
Phase 1/Phase 2 | |
Terminated |
NCT00668564 -
Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism
|
Phase 2 | |
Not yet recruiting |
NCT06308718 -
Long-term Follow-up Study to Evaluate Safety and Efficacy of FBX-101 in Krabbe Patients
|
||
Active, not recruiting |
NCT02699190 -
LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies
|
||
Recruiting |
NCT03333200 -
Longitudinal Study of Neurodegenerative Disorders
|
||
Recruiting |
NCT05739643 -
Gene Transfer Clinical Trial for Infantile and Late Infantile Krabbe Disease Treated Previously With HSCT
|
Phase 1/Phase 2 | |
Recruiting |
NCT03047369 -
The Myelin Disorders Biorepository Project
|
||
Completed |
NCT01043640 -
Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders
|
Phase 2 | |
Withdrawn |
NCT01425489 -
Biomarker for Krabbe Disease (BioKrabbe)
|
||
Active, not recruiting |
NCT00787865 -
Diffusion Tensor Imaging (DTI) in Infants With Krabbe Disease
|